S002 Pearls: Diagnostic and Therapeutic
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Faculty will share innovative approaches to a variety of common and perhaps less common conditions. We will present a number of new cases, new diagnostic approaches, surgical pearls, perhaps some older and forgotten approaches to frustrating conditions, aspects of regenerative medicine, and especially, off-label recommendations. Interesting approaches to dermoscopic diagnoses will also be presented. Attendees are encouraged to email challenging cases or favorite off-label pearls to drspstone@gmail.com for inclusion in our discussions.
LEARNING OBJECTIVES
Use innovative therapies for patients with complicated conditions, or common maladies unresponsive to commonly effective approaches.
Safely and effectively utilize established medications for off label uses.
Diagnose lesions with dermoscopy and appropriately communicate with the pathologist.
SCHEDULE
5:00 PM
Introduction
Stephen P. Stone, MD, FAAD
5:05 PM
Clinicopathologic Pearls
Morgan Wilson, MD, FAAD
5:35 PM
Diagnostic and therapeutic pearls.
Mark Lebwohl, MD, FAAD
6:05 PM
Procedural Dermatology Pearls
Rebecca Jean Larson, MD, FAAD
6:35 PM
Dermoscopy clues for diagnosis and management
Aimilios Lallas, MD, MSc, PhD, IFAAD
7:20 PM
Practical Office Pearls
Stephen P. Stone, MD, FAAD
SPEAKERS
Aimilios Lallas, MD, MSc, PhD, IFAAD
Rebecca Jean Larson, MD, FAAD
Mark Lebwohl, MD, FAAD
Stephen P. Stone, MD, FAAD
Morgan Wilson, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Aimilios Lallas, MD, MSc, PhD, IFAAD
3Gen, LLC – Advisory Board(Equipment); Avène – Speaker/Faculty Education(Honoraria); Bioderma – Speaker(Honoraria); Elsevier Inc. – Other(Fees); Fotofinder – Advisory Board(Equipment); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria);
Rebecca Jean Larson, MD, FAAD
No financial relationships exist with ineligible companies.
Mark Lebwohl, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Stephen P. Stone, MD, FAAD
Abbott Laboratories – Stockholder(Other Financial Benefit); Acuderm, Inc. – Board of Directors(No Compensation Received), Stockholder(No Compensation Received); Becton Dickinson – Stockholder(Other Financial Benefit); Johnson & Johnson Consumer Products Company – Stockholder(Other Financial Benefit); Pfizer Inc. – Stockholder(Other Financial Benefit); Stryker Corporation – Stockholder(Other Financial Benefit);
Morgan Wilson, MD, FAAD
No financial relationships exist with ineligible companies.